PAPER Oksengard AR, Cavallin L, Axelsson R, Andersson C, Nägga K, Winblad B, Eriksdotter-Jönhagen M, Wahlund LO
SEARCH RESULTS
330919 RESULTS
PAPER Viana RJ, Fonseca MB, Ramalho RM, Nunes AF, Rodrigues CM
Organelle stress sensors and cell death mechanisms in neurodegenerative diseases.
CNS Neurol Disord Drug Targets. 2010 Dec;9(6):679-92. PubMed: 20942793PAPER Costa J, Gomes C, de Carvalho M
Diagnosis, pathogenesis and therapeutic targets in amyotrophic lateral sclerosis.
CNS Neurol Disord Drug Targets. 2010 Dec;9(6):764-78. PubMed: 20942786PAPER Munhoz CD, Sorrells SF, Caso JR, Scavone C, Sapolsky RM
Glucocorticoids exacerbate lipopolysaccharide-induced signaling in the frontal cortex and hippocampus in a dose-dependent manner.
J Neurosci. 2010 Oct 13;30(41):13690-8. PubMed: 20943909PAPER Park H, Adsit FG, Boyington JC
The 1.5 Å crystal structure of human receptor for advanced glycation endproducts (RAGE) ectodomains reveals unique features determining ligand binding.
J Biol Chem. 2010 Dec 24;285(52):40762-70. PubMed: 20943659PAPER Sooy K, Webster SP, Noble J, Binnie M, Walker BR, Seckl JR, Yau JL
Partial deficiency or short-term inhibition of 11beta-hydroxysteroid dehydrogenase type 1 improves cognitive function in aging mice.
J Neurosci. 2010 Oct 13;30(41):13867-72. PubMed: 20943927PAPER Ehm O, Göritz C, Covic M, Schäffner I, Schwarz TJ, Karaca E, Kempkes B, Kremmer E, Pfrieger FW, Espinosa L, Bigas A, Giachino C, Taylor V, Frisén J, Lie DC
RBPJkappa-dependent signaling is essential for long-term maintenance of neural stem cells in the adult hippocampus.
J Neurosci. 2010 Oct 13;30(41):13794-807. PubMed: 20943920PAPER Anitha M, Nandhu MS, Anju TR, Jes P, Paulose CS
Targeting glutamate mediated excitotoxicity in Huntington's disease: neural progenitors and partial glutamate antagonist--memantine.
Med Hypotheses. 2011 Jan;76(1):138-40. PubMed: 20943326PAPER Bai Y, Dergham P, Nedev H, Xu J, Galan A, Rivera JC, Zhihua S, Mehta HM, Woo SB, Sarunic MV, Neet KE, Saragovi HU
Chronic and acute models of retinal neurodegeneration TrkA activity are neuroprotective whereas p75NTR activity is neurotoxic through a paracrine mechanism.
J Biol Chem. 2010 Dec 10;285(50):39392-400. PubMed: 20943663PAPER Bosco DA, Landers JE
Genetic determinants of amyotrophic lateral sclerosis as therapeutic targets.
CNS Neurol Disord Drug Targets. 2010 Dec;9(6):779-90. PubMed: 20942785PAPER Pruss RM
Phenotypic screening strategies for neurodegenerative diseases: a pathway to discover novel drug candidates and potential disease targets or mechanisms.
CNS Neurol Disord Drug Targets. 2010 Dec;9(6):693-700. PubMed: 20942792PAPER Vohra BP, Sasaki Y, Miller BR, Chang J, DiAntonio A, Milbrandt J
Amyloid precursor protein cleavage-dependent and-independent axonal degeneration programs share a common nicotinamide mononucleotide adenylyltransferase 1-sensitive pathway.
J Neurosci. 2010 Oct 13;30(41):13729-38. PubMed: 20943913PAPER Butterfield DA, Reed T, Sultana R
Roles of 3-nitrotyrosine- and 4-hydroxynonenal-modified brain proteins in the progression and pathogenesis of Alzheimer's disease.
Free Radic Res. 2011 Jan;45(1):59-72. PubMed: 20942567PAPER Katsarou Z, Bostantjopoulou S, Zikouli A, Kazazi E, Kafantari A, Tsipropoulou V, Kourtesi G, Peitsidou E
Performance of Greek demented and nondemented subjects on the Greek version of the Mattis Dementia Rating Scale. A validation study.
Int J Neurosci. 2010 Nov;120(11):724-30. PubMed: 20942587PAPER Sabayan B, Zamiri N, Farshchizarabi S
Phosphodiesterase-5 inhibitors: novel weapons against Alzheimer's disease?
Int J Neurosci. 2010 Dec;120(12):746-51. PubMed: 20942592Current Filters
No filters selected